Hotez, PJ & Peiperl, L (2015) Noncommunicable diseases: a globalization of disparity? PLoS Med 12, e1001859–2903.
Magnusson, RS (2010) Global health governance and the challenge of chronic, non-communicable disease. J Law Med Ethics 38, 490–507.
Alberti, KG, Eckel, RH & Grundy, SM et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645.
Chatterjee, A, Harris, SB & Leiter, LA et al. (2012) Managing cardiometabolic risk in primary care: summary of the 2011 consensus statement. Can Fam Physician 58, 389–e201.
Reaven, GM (1988) Role of insulin resistance in human disease. Diabetes 37, 1595.
Alberti, KG & Zimmet, PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539–553.
Huang, PL (2009) A comprehensive definition for metabolic syndrome. Dis Model Mech 2, 231–237.
Saklayen, MG (2018) The global epidemic of the metabolic syndrome. Curr Hypertens Rep 20, 12–12.
Kassi, E, Pervanidou, P & Kaltsas, G et al. (2011) Metabolic syndrome: definitions and controversies. BMC Med 9, 48–48.
Misra, A, Chowbey, P & Makkar, BM et al. (2009) Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India 57, 163–170.
Kim, CH, Kim, HK & Kim, EH et al. (2012) Impact of body mass index on the predictive ability of body fat distribution for type 2 diabetes risk in Koreans. Diabetic Medicine 29, 1395–1398.
Resnick, HE, Valsania, P & Halter, JB et al. (1998) Differential effects of BMI on diabetes risk among black and white Americans. Diabetes Care 21, 1828–1835.
Stommel, M & Schoenborn, CA (2010) Variations in BMI and prevalence of health risks in diverse racial and ethnic populations. Obesity 18, 1821–1826.
Alberti, KG, Zimmet, P & Shaw, J (2005) The metabolic syndrome – a new worldwide definition. Lancet 366, 1059–1062.
National Cholesterol Education Program (NCEP) Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106, 3143–3421.
Villanueva, B, Arteaga, A & Maiz, A et al. (2018) Abdominal obesity is a common finding in normal and overweight subjects of Chile and is associated with increased frequency of cardiometabolic risk factors. PLOS ONE 13, e0194644.
Cardinal, TR, Vigo, A, Duncan, BB et al. (2018) Optimal cut-off points for waist circumference in the definition of metabolic syndrome in Brazilian adults: baseline analyses of the Longitudinal Study of Adult Health (ELSA-Brasil). Diabetol Metab Syndr 10, 49.
Mora-García, GJ, Gómez-Camargo, D, Mazenett, E et al. (2014) Anthropometric parameters’ cut-off points and predictive value for metabolic syndrome in women from Cartagena, Colombia. Salud Publica Mex 56(2): 146–153.
WHO (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157–163.
Aschner, P, Buendia, R, Brajkovich, I et al. (2011) Determination of the cutoff point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women. Diabetes Res Clin Pract 93, 243–247.
Bermúdez, JV, Rojas, J, Salazar, J et al. (2014) Optimal waist circumference cut-off point for multiple risk factor aggregation: results from the Maracaibo City Metabolic Syndrome Prevalence Study. Epidemiol Res Int 2014, 9.